YBX1 alleviates ferroptosis in osteoporosis via the ATF4/FSP1 axis in an m5C manner

被引:0
作者
Tong, Lei [1 ]
Chen, Yanbo [1 ]
Gao, Yan [1 ]
Gao, Xiaoming [1 ]
Hao, Yanming [1 ]
机构
[1] Kunshan First Peoples Hosp Joint Surg Dept, 566 Qianjin East Rd, Suzhou 215399, Jiangsu, Peoples R China
来源
JOURNAL OF ORTHOPAEDIC SURGERY AND RESEARCH | 2025年 / 19卷 / 01期
关键词
Osteoporosis; Ferroptosis; Y-box binding protein 1; Activating transcription factor 4; Ferroptosis suppressor protein 1;
D O I
10.1186/s13018-024-05119-7
中图分类号
R826.8 [整形外科学]; R782.2 [口腔颌面部整形外科学]; R726.2 [小儿整形外科学]; R62 [整形外科学(修复外科学)];
学科分类号
摘要
BackgroundInteractions between RNA-binding proteins and RNA regulate RNA transcription during osteoporosis. Ferroptosis, a programmed cell death caused by iron metabolism, plays a vital role in osteoporosis. However, the mechanisms by which RNA-binding proteins are involved in ferroptosis during osteoporosis remain unclear.MethodsWe established an in vitro model of osteoporosis induced by D-galactose (D-gal) in MC3T3-E1 cells. Ferroptosis suppressor protein 1 (FSP1), activating transcription factor 4 (ATF4), and Y-box binding protein 1 (YBX1) knockdown MC3T3-E1 cells were generated, and their effects on ferroptosis were verified by measuring lipid reactive oxygen species levels and cellular Fe2+. Chromatin immunoprecipitation and luciferase assays were performed to confirm the binding of ATF4 to the FSP1 promoter. RNA pulldown and RNA immunoprecipitation experiments were used to determine the binding between YBX1 and ATF4 mRNA and to test the effect of YBX1 on ATF4 mRNA stability in a 5-methylcytosine (m5C)-dependent manner.ResultsFSP1 or YBX1 knockdown led to a D-gal-induced increase in lipid reactive oxygen species levels and cellular Fe2+ in MC3T3-E1 cells, which was alleviated by ATF4 overexpression. ATF4 inhibits ferroptosis by binding to the FSP1 promoter. In addition, YBX1 increased ATF4 mRNA stability through m5C RNA modification and inhibited ferroptosis in MC3T3-E1 cells via the ATF4/FSP1 axis.ConclusionOur results showed that YBX1 could alleviate ferroptosis via the ATF4/FSP1 axis in an m5C-dependent manner in D-gal-induced osteoblasts, suggesting that YBX1 may be a new target for osteoporosis treatment.
引用
收藏
页数:13
相关论文
共 30 条
  • [1] Cao ZH, 2023, AGING-US, V15, P9391, DOI 10.18632/aging.204945
  • [2] Y-box binding protein 1 in small extracellular vesicles reduces mesenchymal stem cell differentiation to osteoblasts-implications for acute myeloid leukaemia
    Chetty, Venkatesh Kumar
    Ghanam, Jamal
    Licha, Kristina
    Brenzel, Alexandra
    Reinhardt, Dirk
    Thakur, Basant Kumar
    [J]. JOURNAL OF EXTRACELLULAR VESICLES, 2024, 13 (03)
  • [3] A Polymorphism at the Translation Start Site of the Vitamin D Receptor Gene Is Associated with the Response to Anti-Osteoporotic Therapy in Postmenopausal Women from Southern Italy
    Conti, Valeria
    Russomanno, Giusy
    Corbi, Graziamaria
    Toro, Giuseppe
    Simeon, Vittorio
    Filippelli, Walter
    Ferrara, Nicola
    Grimaldi, Michela
    D'Argenio, Valeria
    Maffulli, Nicola
    Filippelli, Amelia
    [J]. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2015, 16 (03): : 5452 - 5466
  • [4] FSP1 is a glutathione-independent ferroptosis suppressor
    Doll, Sebastian
    Freitas, Florencio Porto
    Shah, Ron
    Aldrovandi, Maceler
    da Silva, Milene Costa
    Ingold, Irina
    Grocin, Andrea Goya
    da Silva, Thamara Nishida Xavier
    Panzilius, Elena
    Scheel, Christina H.
    Mourao, Andre
    Buday, Katalin
    Sato, Mami
    Wanninger, Jonas
    Vignane, Thibaut
    Mohana, Vaishnavi
    Rehberg, Markus
    Flatley, Andrew
    Schepers, Aloys
    Kurz, Andreas
    White, Daniel
    Sauer, Markus
    Sattler, Michael
    Tate, Edward William
    Schmitz, Werner
    Schulze, Almut
    O'Donnell, Valerie
    Proneth, Bettina
    Popowicz, Grzegorz M.
    Pratt, Derek A.
    Angeli, Jose Pedro Friedmann
    Conrad, Marcus
    [J]. NATURE, 2019, 575 (7784) : 693 - +
  • [5] Evaluating tools for transcription factor binding site prediction
    Jayaram N.
    Usvyat D.
    Martin A.C.
    [J]. BMC Bioinformatics, 17 (1)
  • [6] Jerebtsova Marina, 2012, Biology (Basel), V1, P175
  • [7] ATF4 protects against sorafenib-induced cardiotoxicity by suppressing ferroptosis
    Jiang, Hui
    Wang, Cong
    Zhang, An
    Li, Yufeng
    Li, Jianping
    Li, Zhan
    Yang, Xin
    Hou, Yinglong
    [J]. BIOMEDICINE & PHARMACOTHERAPY, 2022, 153
  • [8] LncRNA RAD51-AS1 Regulates Human Bone Marrow Mesenchymal Stem Cells via Interaction with YBX1 to Ameliorate Osteoporosis
    Li, Beichen
    Wang, Jing
    Xu, Fangrong
    Wang, Qinjue
    Liu, Quan
    Wang, Guantong
    Miao, Dengshun
    Sun, Qiang
    [J]. STEM CELL REVIEWS AND REPORTS, 2023, 19 (01) : 170 - 187
  • [9] YBX1 Promotes Esophageal Squamous Cell Carcinoma Progression via m5C-Dependent SMOX mRNA Stabilization
    Liu, Liwen
    Chen, Yu
    Zhang, Tao
    Cui, Guangying
    Wang, Weiwei
    Zhang, Guizhen
    Li, Jianhao
    Zhang, Yize
    Wang, Yun
    Zou, Yawen
    Ren, Zhigang
    Xue, Wenhua
    Sun, Ranran
    [J]. ADVANCED SCIENCE, 2024, 11 (20)
  • [10] RNA modifications in cellular metabolism: implications for metabolism-targeted therapy and immunotherapy
    Liu, Wei-Wei
    Zheng, Si-Qing
    Li, Tian
    Fei, Yun-Fei
    Wang, Chen
    Zhang, Shuang
    Wang, Fei
    Jiang, Guan-Min
    Wang, Hao
    [J]. SIGNAL TRANSDUCTION AND TARGETED THERAPY, 2024, 9 (01)